4-Phenylpiperidine-4-carboxamide monohydrochloride → 1-[2-[3-(3,4-Dimethoxy-phenyl)-1-(3,4,5-triethoxy-benzoyl)-pyrrolidin-3-yl]-ethyl]-4-phenyl-piperidine-4-carboxylic acid amide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	4-Phenylpiperidine-4-carboxamide monohydrochloride	HCID 3017129	—
Edukt	2-[3-(3,4-Dimethoxy-phenyl)-1-(3,4,5-triethoxy-benzoyl)-pyrrolidin-3-yl]-ethyl-methanesulfonate	HCID 86750914	—
Produkt	1-[2-[3-(3,4-Dimethoxy-phenyl)-1-(3,4,5-triethoxy-benzoyl)-pyrrolidin-3-yl]-ethyl]-4-phenyl-piperidine-4-carboxylic acid amide	HCID 53655323	—

Reaktionsschritte

Prepare by the method of example 3.3 using 2-[3-(3,4-dimethoxy-phenyl)-1-(3,4,5-triethoxy-benzoyl)-pyrrolidin-3-yl]-ethyl-methanesulfonate (8 mmol) and 4-phenyl-piperidine-4-carboxylic acid amide hydrochloride (12 mmol). Chromatograph on silica gel to give the title compound.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US05648366
Quelldatensatz	uspto-grants-1997_07
ORD ID	ord-e2c004a8d6824dffb28318954dc090ab
Quellennotiz	uspto-grants-1997_07